Roger Cachope, M.D. M.S. - Publications

Affiliations: 
CHDI Foundation 
Area:
Huntington's Disease, Dopamine, Endocannabinoids, Synaptic plasticity, Schizophrenia
Website:
http://chdifoundation.org/index.php?option=com_jumi&fileid=3&Itemid=71#87

23/32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Cachope R, Pereda AE. Regulatory Roles of Metabotropic Glutamate Receptors on Synaptic Communication Mediated by Gap Junctions. Neuroscience. PMID 32619474 DOI: 10.1016/J.Neuroscience.2020.06.034  0.674
2019 Zlebnik NE, Gildish I, Sesia T, Fitoussi A, Cole EA, Carson BP, Cachope R, Cheer JF. Motivational Impairment is Accompanied by Corticoaccumbal Dysfunction in the BACHD-Tg5 Rat Model of Huntington's Disease. Cerebral Cortex (New York, N.Y. : 1991). PMID 30753343 DOI: 10.1093/Cercor/Bhz009  0.58
2019 Perez-Rosello T, Gelman S, Tombaugh G, Cachope R, Beaumont V, Surmeier DJ. Enhanced striatopallidal gamma-aminobutyric acid (GABA) receptor transmission in mouse models of huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30726572 DOI: 10.1002/Mds.27622  0.348
2019 Wang HL, Zhang S, Qi J, Wang H, Cachope R, Mejias-Aponte CA, Gomez JA, Mateo-Semidey GE, Beaudoin GMJ, Paladini CA, Cheer JF, Morales M. Dorsal Raphe Dual Serotonin-Glutamate Neurons Drive Reward by Establishing Excitatory Synapses on VTA Mesoaccumbens Dopamine Neurons. Cell Reports. 26: 1128-1142.e7. PMID 30699344 DOI: 10.1016/J.Celrep.2019.01.014  0.7
2017 Mateo Y, Johnson KA, Covey DP, Atwood BK, Wang HL, Zhang S, Gildish I, Cachope R, Bellocchio L, Guzmán M, Morales M, Cheer JF, Lovinger DM. Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens. Neuron. 96: 1112-1126.e5. PMID 29216450 DOI: 10.1016/J.Neuron.2017.11.012  0.518
2017 Terrillion CE, Dao DT, Cachope R, Lobo MK, Puche AC, Cheer JF, Gould TD. Reduced levels of Cacna1c attenuate mesolimbic dopamine system function. Genes, Brain, and Behavior. PMID 28186690 DOI: 10.1111/Gbb.12371  0.66
2016 Can A, Frost DO, Cachope R, Cheer JF, Gould TD. Chronic Lithium Treatment Rectifies Maladaptive Dopamine Release in the Nucleus Accumbens. Journal of Neurochemistry. PMID 27513916 DOI: 10.1111/Jnc.13769  0.641
2016 Cockerham R, Liu S, Cachope R, Kiyokage E, Cheer JF, Shipley MT, Puche AC. Subsecond Regulation of Synaptically Released Dopamine by COMT in the Olfactory Bulb. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 7779-85. PMID 27445153 DOI: 10.1523/Jneurosci.0658-16.2016  0.688
2015 Bagot RC, Parise EM, Peña CJ, Zhang HX, Maze I, Chaudhury D, Persaud B, Cachope R, Bolaños-Guzmán CA, Cheer JF, Deisseroth K, Han MH, Nestler EJ. Corrigendum: Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nature Communications. 6: 7626. PMID 26080619 DOI: 10.1038/Ncomms8626  0.572
2015 Cachope R, Pereda AE. Opioids potentiate electrical transmission at mixed synapses on the Mauthner cell. Journal of Neurophysiology. 114: 689-97. PMID 26019311 DOI: 10.1152/Jn.00165.2015  0.685
2015 Bagot RC, Parise EM, Peña CJ, Zhang HX, Maze I, Chaudhury D, Persaud B, Cachope R, Bolaños-Guzmán CA, Cheer J, Deisseroth K, Han MH, Nestler EJ. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nature Communications. 6: 7062. PMID 25952660 DOI: 10.1038/Ncomms8062  0.625
2014 Cachope R, Cheer JF. Local control of striatal dopamine release. Frontiers in Behavioral Neuroscience. 8: 188. PMID 24904339 DOI: 10.3389/Fnbeh.2014.00188  0.683
2014 Oleson EB, Cachope R, Fitoussi A, Tsutsui K, Wu S, Gallegos JA, Cheer JF. Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1441-52. PMID 24345819 DOI: 10.1038/Npp.2013.340  0.755
2014 Oleson EB, Cachope R, Fitoussi A, Cheer JF. Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 17-23. PMID 23911441 DOI: 10.1016/J.Pnpbp.2013.07.019  0.748
2014 Pereda AE, Curti S, Hoge G, Cachope R, Flores CE, Rash JE. Corrigendum to “Gap junction-mediated electrical transmission: Regulatory mechanisms and plasticity” [Biochim. Biophys. Acta 1828 (2013) 134–146] Biochimica Et Biophysica Acta (Bba) - Biomembranes. 1838: 1056. DOI: 10.1016/J.Bbamem.2013.10.013  0.722
2013 Lobo MK, Zaman S, Damez-Werno DM, Koo JW, Bagot RC, DiNieri JA, Nugent A, Finkel E, Chaudhury D, Chandra R, Riberio E, Rabkin J, Mouzon E, Cachope R, Cheer JF, et al. ΔFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18381-95. PMID 24259563 DOI: 10.1523/Jneurosci.1875-13.2013  0.659
2013 Pereda AE, Curti S, Hoge G, Cachope R, Flores CE, Rash JE. Gap junction-mediated electrical transmission: regulatory mechanisms and plasticity. Biochimica Et Biophysica Acta. 1828: 134-46. PMID 22659675 DOI: 10.1016/J.Bbamem.2012.05.026  0.725
2012 Cachope R. Functional diversity on synaptic plasticity mediated by endocannabinoids. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3242-53. PMID 23108543 DOI: 10.1098/Rstb.2011.0386  0.437
2012 Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M, Lovinger DM, Cheer JF. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Reports. 2: 33-41. PMID 22840394 DOI: 10.1016/J.Celrep.2012.05.011  0.776
2012 Cachope R, Pereda AE. Two independent forms of activity-dependent potentiation regulate electrical transmission at mixed synapses on the Mauthner cell. Brain Research. 1487: 173-82. PMID 22771708 DOI: 10.1016/J.Brainres.2012.05.059  0.702
2012 Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF, Lichtman AH, Cheer JF. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron. 73: 360-73. PMID 22284189 DOI: 10.1016/J.Neuron.2011.11.018  0.762
2010 Flores CE, Cachope R, Nannapaneni S, Ene S, Nairn AC, Pereda AE. Variability of distribution of Ca(2+)/calmodulin-dependent kinase II at mixed synapses on the mauthner cell: colocalization and association with connexin 35. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 9488-99. PMID 20631177 DOI: 10.1523/Jneurosci.4466-09.2010  0.737
2007 Cachope R, Mackie K, Triller A, O'Brien J, Pereda AE. Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids. Neuron. 56: 1034-47. PMID 18093525 DOI: 10.1016/J.Neuron.2007.11.014  0.714
Low-probability matches (unlikely to be authored by this person)
2017 Whittaker DS, Wang HB, Loh DH, Cachope R, Colwell CS. Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease. Pharmacology Research & Perspectives. 5. PMID 28971617 DOI: 10.1002/Prp2.344  0.28
2017 Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R. Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease. Trends in Neurosciences. PMID 28578789 DOI: 10.1016/J.Tins.2017.05.002  0.272
2019 Toledo-Sherman LM, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Cox HC, McAllister G, Penrose SD, Vater H, Esmieu W, Van de Poël A, Van de Bospoort R, et al. "Optimization of potent and selective Ataxia Telangiectasia Mutated (ATM) inhibitors suitable for a proof-of-concept study in Huntington's disease models". Journal of Medicinal Chemistry. PMID 30840447 DOI: 10.1021/Acs.Jmedchem.8B01819  0.236
2018 Piiponniemi TO, Parkkari T, Heikkinen T, Puoliväli J, Park LC, Cachope R, Kopanitsa MV. Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task. Frontiers in Behavioral Neuroscience. 12: 226. PMID 30333735 DOI: 10.3389/Fnbeh.2018.00226  0.228
2023 Adhikari MH, Vasilkovska T, Cachope R, Tang H, Liu L, Keliris GA, Munoz-Sanjuan I, Pustina D, Van der Linden A, Verhoye M. Longitudinal investigation of changes in resting-state co-activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington's disease. Scientific Reports. 13: 10194. PMID 37353500 DOI: 10.1038/s41598-023-36812-y  0.128
2023 Vasilkovska T, Adhikari M, Van Audekerke J, Salajeghe S, Pustina D, Cachope R, Tang H, Liu L, Munoz-Sanjuan I, Van der Linden A, Verhoye M. Resting-state fMRI reveals longitudinal alterations in brain network connectivity in the zQ175DN mouse model of Huntington's disease. Neurobiology of Disease. 106095. PMID 36963694 DOI: 10.1016/j.nbd.2023.106095  0.116
2022 Ladduwahetty T, Lee MR, Maillard MC, Cachope R, Todd D, Barnes M, Beaumont V, Chauhan A, Gallati C, Haughan AF, Kempf G, Luckhurst CA, Matthews K, McAllister G, Mitchell P, et al. Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington's Disease. Journal of Medicinal Chemistry. PMID 35816678 DOI: 10.1021/acs.jmedchem.2c00474  0.09
2021 Van de Poël A, Toledo-Sherman L, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Peacock M, Barnard A, Cox HC, Jones G, McAllister G, Vater H, et al. Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease. Journal of Medicinal Chemistry. PMID 33783225 DOI: 10.1021/acs.jmedchem.1c00114  0.067
2024 Vidas-Guscic N, van Rijswijk J, Van Audekerke J, Jeurissen B, Nnah I, Tang H, Munoz-Sanjuan I, Pustina D, Cachope R, Van der Linden A, Bertoglio D, Verhoye M. Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington's disease. Neurobiology of Disease. 106438. PMID 38365045 DOI: 10.1016/j.nbd.2024.106438  0.066
Hide low-probability matches.